The Global Coalition for Adaptive Research (GCAR) unites physicians, clinical researchers, advocacy and philanthropic organizations, biotech/pharma, health authorities, and other key stakeholders in healthcare to expedite the discovery and development of treatments for patients with rare and deadly diseases. As Sponsor of innovative trials, including master protocols and adaptive platform trials, GCAR is dedicated to the advancement of science by modernizing clinical trials that support more efficient, less costly drug development. Adaptive platform trials deliver an unmatched accelerated time from discovery in the lab to implementation in the clinic resulting in better treatments and lives saved. 



Biotechnology

Clinical Trials

Health Care

Life Sciences

Global Coalition for Adaptive Research

Meredith Buxton

Ashley A. Powell

Rachel Rosenstein-Sisson

Matthew Viva

Tracey Roberts

Adam Johnson

Rob Murray

Rachael Coleman

Clinical Operations and Trial Management

Leadership Team

Teams at Global Coalition for Adaptive Research

Clinical Operations and Trial Management

Leadership Team